Tuberculosis Treatment and Resulting Abnormal Blood Glucose: a Scoping Review of Studies from 1981 - 2021
Tuberculosis Treatment and Resulting Abnormal Blood Glucose: a Scoping Review of Studies from 1981 - 2021
Date
Authors
Williams, Victor
Onwuchekwa, Chukwuemeka
Grobbee, Diederick E
Otwombe, Kennedy
Klipstein-Grobusch, Kerstin
Type
Article, Journal
Journal Title
Journal ISSN
Volume Title
Publisher
Type
Article, Journal
Abstract
Hyperglycaemia is a risk factor for tuberculosis. Evidence of changes in blood glucose levels during and after tuberculosis treatment is unclear. Conclusion: Elevated blood glucose in normoglycaemic patients receiving treatment for tuberculosis decreased by the end of treatment. Positive HIV status did not affect glucose changes during treatment. Further research is needed to investigate post-treatment morbidity in patients with baseline hyperglycaemia and the effects of HIV on the association between blood glucose and tuberculosis.
Description
Keywords
Diabetes, hyperglycaemia, impaired glucose tolerance, human immunodeficiency virus
Citation
Williams V, Onwuchekwa C, Vos AG, Grobbee DE, Otwombe K, Klipstein-Grobusch K. Tuberculosis treatment and resulting abnormal blood glucose: a scoping review of studies from 1981 - 2021. Glob Health Action. 2022 Dec 31;15(1):2114146. doi: 10.1080/16549716.2022.2114146. PMID: 36178364; PMCID: PMC9543146.